WHY YOU SHOULD SUPPORT THE LLS

The mission of The Leukemia & Lymphoma Society (LLS) is to: cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.

Blood Cancer is the #3 Killer

Only lung and gastrointestinal cancers take more lives in the US each year. But, less than 1 in 10 new cancer diagnoses will be a blood cancer. And, there are many rare sub-types of leukemia’s, lymphomas and myelomas. Without donations from people like you, research into treatments would not be possible.

Leukemia is Most Common in Children

Since LLS began investing in research in 1949, the 5-year survival rate for children with acute lymphoblastic leukemia has improved from 5% to approximately 90%. Despite this improvement, leukemia causes more deaths than any other cancer among children, adolescents, and young adults.

LLS Research Has Been Utilized For Many Types of Cancers

Approximately 40% of new cancer therapies approved by the FDA between 2000 and 2017 were first approved for blood cancer patients and many are now helping patients with other serious diseases.  25% of more than 900 new cancer treatments in clinical testing by companies (as of June 2012) were first tested as treatments for blood cancer patients. These treatments include Chemotherapy, Bone Marrow Transplants, Molecular Targeting, and the first-ever FDA approved gene-therapy (Car-T).

Invest in Finding Cures

The Leukemia & Lymphoma Society (LLS) is the largest voluntary cancer research agency specifically focused on finding cures and better treatments for blood cancer patients. With the scope and scale to fund many projects at the same time, LLS supports hundreds of cancer scientists around the world and was  the first-ever non-profit to be awarded a Master Trial (Beat-AML).

Research Depends on You

Unlike commercial enterprises that consider blood cancers as “orphan diseases” with small markets and limited profit potential, LLS funds research based on medical need without regard to commercial return or market size. Every dollar invested comes from charitable support from concerned donors.

Extend Your Reach

LLS funds hundreds of promising researchers at leading cancer centers and universities worldwide. And since LLS has no campus or laboratories to maintain, your investment funds more research and less overhead than a donation made elsewhere.

ABOUT THE LLS MAN & WOMAN OF THE YEAR

The Leukemia & Lymphoma Society’s Man & Woman of the Year (MWOY) campaign is a fundraising competition in communities across the U.S. in which participants vie for the title of Man or Woman of the Year. They raise funds for blood cancer research in honor of local children who are blood cancer survivors, the Boy & Girl of the Year. The titles are awarded to the men and women in each community who raise the most funds during the ten-week campaign; the top local fundraisers in the country also win the national titles.

Each year, in communities across the country, dynamic, passionate candidates engage in a spirited competition to earn The Leukemia & Lymphoma Society’s “Man & Woman of the Year” titles, by raising funds for blood cancer research. The candidates compete in honor of children who are local blood cancer survivors, the Boy & Girl of the Year. Every dollar counts as one vote, and the titles are awarded to the man and woman with the most votes at the end of ten weeks; the top local fundraisers in the country win the national titles.

MEET COAST TO COAST CURES CANDIDATE’S

MEET THE BOY & GIRL OF THE YEAR